FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
O. Roopnarine, S. L. Yuen, A. R. Thompson, L. N. Roelike, R. T. Rebbeck, P. A. Bidwell, C. C. Aldrich, R. L. Cornea, D. D. Thomas
The paper uses a FRET assay to screen compounds affecting the cardiac SERCA pump, identifying activators and inhibitors with potential therapeutic applications for heart failure.
bioRxiv · Feb 22, 2023 · PreprintBiophysics